Tag: court-on-monday
-
Stryker, Halo to get second chance at enhanced patent damages
By Andrew Chung NEW YORK (Reuters) – The U.S. Supreme Court on Monday said federal judges should have more discretion to boost penalties in patent infringement cases and ordered an appeals court to review whether Zimmer Biomet Holdings Inc willfully violated Stryker Corp patents on a surgical cleaning wand. In a unanimous opinion, the high…
-
Supreme Court rejects challenge to Obama mercury air pollution rule
By Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Monday turned aside the latest effort by a group of states led by Michigan to block Obama administration environmental regulations limiting power plant emissions of mercury and other toxic pollutants. The justices opted not to hear the states' appeal of a December U.S. appeals…
-
U.S. top court rejects suit against Colorado over marijuana law
The U.S. Supreme Court on Monday threw out a lawsuit filed by the states of Nebraska and Oklahoma against their neighbor Colorado over a law approved as a ballot initiative by Colorado voters in 2012 that allows the recreational use of marijuana. The court declined to hear the case filed by Nebraska and Oklahoma, which…
-
BioMarin drug fails to show inattention, mood benefit in study
BioMarin Pharmaceutical Inc’s drug met a study’s main goal of reducing a toxic buildup of an amino acid in the blood of patients with a genetic disorder, but did not show enough benefit in related inattention and mood complications. BioMarin’s shares fell as much as 6 percent in early trading on Monday after the company…
-
Illicit drugs? How Brexit risks legal limbo for medicines
By Ben Hirschler LONDON (Reuters) – A British vote to leave the European Union would threaten some prescription medicines with regulatory limbo, posing a legal headache for drugmakers, according to lawyers and industry officials. The highly regulated pharmaceutical sector has more at stake than most from a so-called Brexit, prompting top manufacturers GlaxoSmithKline and AstraZeneca…